SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 22, 16:20
645.00
3.9 (0.61%)
VOLUME 324,352
LIVE
NSE
Aug 22, 12:50
644.50
3.35 (0.52%)
VOLUME 1,737,631
Business News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Bitter pill gets bitterer: Ranbaxy faces Rs 240-cr US fine

8.35 am | 22 Aug 2014 |  Source: Moneycontrol.com

While specific details of the fine are still awaited, CNBC-TV18 reports the fine by the US Department of Justice could be possibly over violations in ...

Why capex of top 20 Indian pharma firms is set to jump 40%

3.05 pm | 13 Aug 2014 |  Source: Moneycontrol.com

Out of this lot of 20, the capex spending of 8 companies – which currently generate a majority of revenues domestically – will almost double by fi...

USFDA lists 6 deviations on Ipca Labs' Ratlam API unit 

8.24 am | 08 Aug 2014 |  Source: CNBC-TV18

Ipca Labs will be in focus today as the USFDA lists serious deviations on Ratlam API facility. Archana Shukla has more details....

Ranbaxy inks pact with Cipher to sell acne drug in Brazil

7.13 pm | 24 Jul 2014 |  Source: PTI

The licensing agreement extends Ranbaxy's current relationship with Cipher, under which it is marketing isotretinoin capsules in the US under the bran...

How new price control list impacts Indian pharma cos

10.42 am | 23 Jul 2014 |  Source: Moneycontrol.com

With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to c...

See lot of good M&A deals in H2 2014 too: Grant Thornton 

7.07 pm | 16 Jul 2014 |  Source: Moneycontrol.com

According to Lahiri, pharma and e-commerce have been the big winners in the first half with mega deals like Sun Pharma acquiring Ranbaxy and Flipkart ...

Price control debate: Is the pharma sector crying 'wolf'? 

6.25 pm | 16 Jul 2014 |  Source: CNBC-TV18

CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and CM Gulati is Editor, Monthly Index of Medical Specialities (MIMS) to get thei...

See more drug price caps; max impact on Sanofi: Expert 

10.09 am | 16 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

Anti-diabetes, cardiovascular drugs to get upto 35% cheaper 

4.45 pm | 14 Jul 2014 |  Source: CNBC-TV18

NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the gove...

See prices of cardiac drugs reduce by 15-50%: Ex-MD Pfizer 

12.12 pm | 14 Jul 2014 |  Source: CNBC-TV18

According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines...

Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.